# US 2012/0251450 A1 · Nanoparticles that preferentially associate with and kill diseased cells for diagnostic and therapeutic applications

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251450 A1
- Document ID: US20120251450A1
- Status: Published application
- Kind: A1
- Application number: 13/079,594
- Filed: 2011-04-04
- Published: 2012-10-04
- Earliest claimed: 2011-04-04
- Inventors: Alex Punnoose; Denise Wingett
- Web page: https://patentgrep.com/patent/US20120251450A1

## CPC

- A61K 49/0093: {Nanoparticle, nanocapsule, nanobubble, nanosphere, nanobead, i.e. having a size or diameter smaller than 1 micrometer, e.g. polymeric nanoparticle}
- A61K 33/08: Oxides; Hydroxides
- A61K 33/24: Heavy metals; Compounds thereof
- A61K 33/241: Lead; Compounds thereof
- A61K 33/26: Iron; Compounds thereof
- A61K 33/30: Zinc; Compounds thereof
- A61K 33/32: Manganese; Compounds thereof
- A61K 33/34: Copper; Compounds thereof
- A61K 33/38: Silver; Compounds thereof
- A61K 49/0043: {Fluorescein, used in vivo}
- G01N 33/54333: {Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction}
- G01N 33/54346: {Nanoparticles}
- A61K 9/5115: {Inorganic compounds}
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES

## Abstract

Of the many compositions and methods provided herein, one composition includes a nanoparticle having a first oxide of a first metal and a dopant that includes an ion or an atom of a second metal. A method includes a method comprising providing a plurality of nanoparticles comprising a first oxide of a first metal and a dopant that comprises an ion or an atom of a second metal; providing a diseased cell and a healthy cell; contacting the diseased cell and the healthy cell with the nanoparticle; and allowing the nanoparticle to preferentially associate with the diseased cell.

## Claims

### Claim 1

A nanoparticle comprising:
a first oxide of a first metal and
a dopant, wherein the dopant comprises an ion or an atom of a second metal.

### Claim 2 (depends on 1)

The nanoparticle of claim 1, wherein the dopant is substantially at the surface of the oxide.

### Claim 3 (depends on 1)

The nanoparticle of claim 1, wherein the dopant comprises a cluster configuration.

### Claim 4 (depends on 1)

The nanoparticle of claim 1, further comprising a metal oxide core, wherein the oxide and the dopant form a shell surrounding the metal oxide core.

### Claim 5 (depends on 1)

The nanoparticle of claim 1 further comprising a fluorophore.

### Claim 6 (depends on 1)

The nanoparticle of claim 1, wherein the first oxide comprises a material selected from the group consisting of an oxide of: magnesium, calcium, strontium, barium, scandium, titanium, vanadium, chromium, manganese, iron, cobalt, nickel, copper, zinc, molybdenum, ruthenium, palladium, silver, cadmium, tungsten, neodymium, gadolinium, erbium, aluminum, silicon, gallium, germanium, indium, tin, lead, all oxidation states thereof, and any combination thereof.

### Claim 7 (depends on 1)

The nanoparticle of claim 1, wherein the second metal is selected from the group consisting of: magnesium, calcium, strontium, barium, scandium, titanium, vanadium, chromium, manganese, iron, cobalt, nickel, copper, zinc, molybdenum, ruthenium, palladium, silver, cadmium, tungsten, neodymium, gadolinium, erbium, aluminum, silicon, gallium, germanium, indium, tin, lead, all oxidation states thereof, and any combination thereof.

### Claim 8 (depends on 1)

The nanoparticle of claim 1, wherein the dopant is about 0.1% to about 15% w/w of the first oxide of the first metal.

### Claim 9 (depends on 1)

The nanoparticle of claim 1, further comprising a surface coating.

### Claim 10

A method comprising:
providing a plurality of nanoparticles comprising a first oxide of a first metal and a dopant that comprises an ion or an atom of a second metal;
providing a diseased cell and a healthy cell;
contacting the diseased cell and the healthy cell with the nanoparticle; and
allowing the nanoparticle to preferentially associate with the diseased cell.

### Claim 11 (depends on 10)

The method of claim 10, wherein at least one of the nanoparticles comprises the first oxide and the dopant is in the form of a shell encapsulating a metal oxide core.

### Claim 12 (depends on 10)

The method of claim 10, wherein the nanoparticle is not associated with a targeting ligand.

### Claim 13 (depends on 11)

The method of claim 11 further comprising detecting a location of the nanoparticle in vitro, in vivo, or ex vivo.

### Claim 14 (depends on 10)

The method of claim 10 further comprising allowing the nanoparticle to induce a cytotoxic effect in the diseased cell.

### Claim 15 (depends on 10)

The method of claim 10, wherein the diseased cell is an activated T-cell and the healthy cell is a resting T-cell.

### Claim 16 (depends on 10)

The method of claim 10, wherein the diseased cell is a cancer cell.

### Claim 17 (depends on 10)

The method of claim 10, wherein the diseased cell and the healthy cell are in a patient.

### Claim 18

A kit comprising:
a plurality of nanoparticles comprising a first oxide of a first metal and a dopant that comprises an ion or an atom of a second metal; and
a set of instructions for use.

### Claim 19 (depends on 18)

The kit of claim 18, wherein at least one of the nanoparticles is a core-shell nanoparticle such that a shell comprises the first oxide and the dopant.

### Claim 20 (depends on 18)

The kit of claim 18 further comprising a means of administering the nanoparticle to a patient.
